KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Short-term Investments (2016 - 2025)

Astrana Health (ASTH) has disclosed Short-term Investments for 12 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • Quarterly Short-term Investments fell 48.13% to $1.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Sep 2025, down 48.13% year-over-year, with the annual reading at $2.4 million for FY2024, 4.8% down from the prior year.
  • Short-term Investments hit $1.2 million in Q3 2025 for Astrana Health, down from $2.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $187.2 million in Q2 2021 to a low of $1.2 million in Q3 2025.
  • Historically, Short-term Investments has averaged $30.9 million across 5 years, with a median of $3.8 million in 2023.
  • Biggest five-year swings in Short-term Investments: surged 89100.0% in 2021 and later tumbled 90.92% in 2023.
  • Year by year, Short-term Investments stood at $53.4 million in 2021, then plummeted by 89.58% to $5.6 million in 2022, then plummeted by 55.13% to $2.5 million in 2023, then fell by 4.8% to $2.4 million in 2024, then crashed by 48.65% to $1.2 million in 2025.
  • Business Quant data shows Short-term Investments for ASTH at $1.2 million in Q3 2025, $2.4 million in Q2 2025, and $2.4 million in Q1 2025.